MedTrace Logo

Physical Activity Intervention for Gestational Diabetes

NCT03664089 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2022-07-20

No results posted yet for this study

Summary

Gestational diabetes mellitus (GDM) portends an immediate, increased risk for Type 2 diabetes mellitus (T2DM). The increased risk associated with having GDM is compounded by excess weight retention. Therefore, the weeks and months immediately after a GDM-complicated pregnancy present an optimal window to initiate lifestyle changes to prevent or delay T2DM. The long-term goal is to prevent T2DM among women with GDM. This study's objective is to evaluate the efficacy of a novel, yet simple, activity-boosting intervention on weight loss among women with GDM.

Conditions

  • Gestational Diabetes

Interventions

BEHAVIORAL

Ankle weights (2.5 pounds [1.1 kg]/ankle)

Women will receive the standard recommendation for engaging in 150 minutes of physical activity per week, ankle weights (2.5 pounds \[1.1 kg\]/ankle), documentation for ankle weight usage, an accelerometer, and instructions for accelerometer usage.

BEHAVIORAL

Control

Women will receive the standard recommendation for engaging in 150 minutes of physical activity per week.

Sponsors & Collaborators

  • Ohio Department of Health

    collaborator UNKNOWN

  • Ohio State University

    collaborator OTHER

  • American Diabetes Association

    collaborator OTHER

  • Sarah Keim

    lead OTHER

Principal Investigators

  • Sarah Keim, PhD, MA, MS · Nationwide Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-10
Primary Completion
2022-02-22
Completion
2022-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03664089 on ClinicalTrials.gov